Search Results - "Saleh, Yacob"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Effect of level of hormone-receptor expression on treatment outcomes of “triple-positive” early-stage breast cancer by Abdel-Razeq, Hikmat, Edaily, Sara, Iweir, Sereen, Salam, Mourad, Saleh, Yacob, Sughayer, Maher, Salama, Osama, Mustafa, Rawan, Al-Masri, Yosra, Bater, Rayan, Taqash, Ayat

    Published in Breast cancer research and treatment (01-01-2021)
    “…Purpose Breast cancer that overexpresses the human epidermal growth factor receptor-2 (HER2) and both estrogen (ER) and progesterone (PR) receptors is recently…”
    Get full text
    Journal Article
  2. 2

    Surrogate endpoints for overall survival in advanced hepatocellular carcinoma: A meta-analysis by Saleh, Yacob, Baskurt, Zeynep, Farooq, Abdul Rehman, Goodwin, Rachel Anne, Knox, Jennifer J., Chen, Eric X

    Published in Journal of clinical oncology (20-01-2024)
    “…563 Background: Recent advances in systemic therapies have resulted in improved overall survivals (OS) for patients with advanced hepatocellular carcinoma…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Abstract PS5-30: Effect of level of hormone-receptor expression on treatment outcomes of “triple-positive” early-stage breast cancer by Abdel-Razeq, Hikmat, Edaily, Sarah, Iweir, Sereen, Salam, Mourad, Saleh, Yacob, Sughayer, Maher, Salama, Osama, Mustafa, Rawan, Almasri, Yosra, Bater, Rayan, Taqash, Ayat

    Published in Cancer research (Chicago, Ill.) (15-02-2021)
    “…Abstract Introduction: 20-25% of breast cancers overexpress the human epidermal growth factor receptor-2 (HER2) and have an aggressive clinical behavior;…”
    Get full text
    Journal Article
  5. 5

    Hepatocellular Carcinoma: The Evolving Role of Systemic Therapies as a Bridging Treatment to Liver Transplantation by Saleh, Yacob, Abu Hejleh, Taher, Abdelrahim, Maen, Shamseddine, Ali, Chehade, Laudy, Alawabdeh, Tala, Mohamad, Issa, Sammour, Mohammad, Turfa, Rim

    Published in Cancers (30-05-2024)
    “…Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths. Classically, liver transplantation (LT) can be curative for HCC tumors…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Rechallenging nivolumab following immune checkpoint inhibitor-induced pericarditis by Ali, Mustafa Rami, Darwish, Omar Jamil, Alhuneafat, Laith, Abdallah, Bayan Nidal, Saleh, Yacob

    “…We report a case of recurrent pericarditis as an immune-related adverse event in a 47-year-old man with de novo metastatic renal cell carcinoma. After…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Impact of Central Nervous System International Prognostic Index on the Treatment of Diffuse Large B Cell Lymphoma by Ma'koseh, Mohammad, Tamimi, Faris, Abufara, Alaa, Abusalem, Lana, Salama, Osama, Saleh, Jacob, Khader, Rnad, Faiyoumi, Baha A, Al-Rwashdeh, Mohammad, Halahleh, Khaled

    Published in Curēus (Palo Alto, CA) (01-08-2021)
    “…Background The central nervous system international prognostic index (CNS-IPI) is being used widely for the identification of patients with diffuse large B…”
    Get full text
    Journal Article
  14. 14

    Rechallenging nivolumab following immune checkpoint inhibitor-induced pericarditis by Ali, Mustafa Rami, Darwish, Omar Jamil, Alhuneafat, Laith, Abdallah, Bayan Nidal, Saleh, Yacob

    “…We report a case of recurrent pericarditis as an immune-related adverse event in a 47-year-old man with de novo metastatic renal cell carcinoma. After…”
    Get full text
    Report
  15. 15